El Mezouari El Mostafa, Belhadj Ayoub, Ziani Mohamed, Boughanem Mohamed, Moutaj Redouane
Service de Parasitologie Mycologie, Hôpital Militaire Avicenne Marrakech, Maroc.
Service de Réanimation Médicale, Hôpital Militaire Avicenne Marrakech, Maroc.
Pan Afr Med J. 2016 Nov 21;25:179. doi: 10.11604/pamj.2016.25.179.8558. eCollection 2016.
Imported malaria is being seen with increasing frequency in non-endemic areas. Severe forms represent 10% of cases of Plasmodium falciparum malaria. In Morocco, more than 50 cases of malaria occur each year, 83% of which with Plasmodium falciparum malaria. All patients with severe malaria admitted to the Intensive Care Unit during the period between 1 November 2009 and 31 December 2015 were enrolled in our study. The main epidemiological data, the reasons for admission, the management and the outcomes of patients were studied. Thirteen patients were included in our study. The average age was 31 years. All patients had been living in sub-Saharan Africa and had no immunity to malaria. Chemoprophylaxis was adequate in 33% of cases. The mean time between symptom onset and treatment initiation was six days. Mean initial parasitemia was 12%. The main reasons for ICU admission included coma (15%), convulsion (07%), respiratory distress 07%), prostration (07%), renal failure (07%), shock associated with jaundice and acidosis (07%) and kidney failure associated with coma (07%). All patients were treated with intravenous quinine loading dose. Mortality rate was 23%. The causes of death were multi-system organ failure and acute respiratory distress syndrome. Mortality associated with severe malaria remains high. The adequacy of chemoprophylaxis associated with early diagnosis and treatment would significantly improve the prognosis of this parasitic infection.
在非疟疾流行地区,输入性疟疾的出现频率日益增加。重症形式占恶性疟原虫疟疾病例的10%。在摩洛哥,每年有超过50例疟疾发生,其中83%为恶性疟原虫疟疾。2009年11月1日至2015年12月31日期间入住重症监护病房的所有重症疟疾患者均纳入我们的研究。我们研究了主要的流行病学数据、入院原因、治疗方法及患者的预后情况。我们的研究纳入了13名患者。平均年龄为31岁。所有患者均生活在撒哈拉以南非洲地区,对疟疾没有免疫力。33%的病例化学预防措施得当。症状出现至开始治疗的平均时间为6天。初始平均疟原虫血症为12%。入住重症监护病房的主要原因包括昏迷(15%)、惊厥(7%)、呼吸窘迫(7%)、极度虚弱(7%)、肾衰竭(7%)、伴有黄疸和酸中毒的休克(7%)以及伴有昏迷的肾衰竭(7%)。所有患者均接受了静脉注射奎宁负荷剂量治疗。死亡率为23%。死亡原因是多系统器官衰竭和急性呼吸窘迫综合征。与重症疟疾相关的死亡率仍然很高。化学预防措施的得当性以及早期诊断和治疗将显著改善这种寄生虫感染的预后。